Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Salivary Gland Malignancy × Panitumumab × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Carcinoma, Squamous Cell 3 Neoplasms 2 Carcinoma 2 Tongue Neoplasms 1 Salivary Gland Malignancy 1 Recurrence 1 Neoplasm Metastasis 1 Carcinoma, Adenosquamous 1 Advanced Head and Neck Squamous Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01634880 2016-05-23

Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies

The University of Texas Health Science Center at San Antonio

Phase 2 Withdrawn

Salivary Gland Malignancy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡